A previous study has shown that PRMT5 directly methylated E2F1 and regulates the cell cycle, which is required for gating the function of E2F1, suggesting that E2F1 methylation by PRMT5 leads to cancer cell cycle progression. The gene discussed is PRMT5; the disease is cancer.